Risperdal Lawsuit Lawyers
Serving Maryland, Washington, D.C. & Virginia
Many of us have heard of Risperdal (Risperidone) in the news recently. In November 2013, Johnson & Johnson, the manufacturer of this powerful antipsychotic drug, paid $2.2 billion dollars in civil and criminal settlements for allegedly off-label marketing the drug by promoting it for uses not approved by the FDA. This is the third-largest pharmaceutical settlement in history. However, that is not the end of Risperdal’s story.
The attorneys at Ashcraft & Gerel are investigating potential lawsuits on behalf of boys and young men who have developed gynecomastia, an irreversible disease in which males develop breasts, after using Risperdal.
Risperdal & Gynecomastia
The drug Risperdal (Risperidone), manufactured by Johnson & Johnson, is prescribed to treat psychiatric disorders, including schizophrenia, bipolar disorder, and behavioral problems in people with autism. The FDA first approved Risperdal in 1994 for the treatment of schizophrenia. In 2006 and 2007, the FDA approved the drug for use in treating other psychological disorders.
Risperdal has been shown to produce gynecomastia, or the development of male breasts, in boys and young men who have taken the drug.
Symptoms of gynecomastia include:
- Asymmetrical breast enlargement
- Swollen nipples
- Nipple discharge
- Breast tenderness
- Redness or discoloration around the nipple
Gynecomastia is a potentially embarrassing condition that can cause major psychological trauma and lowered self-esteem to those afflicted with it. Some may even require surgery in order to remove the excess breast tissue. In less serious cases, liposuction could be performed. In other cases, however, a full mastectomy is required, which involves the complete removal of breast tissue and excess skin. In addition to the expense of these procedures, they can also cause psychological stress and anxiety.
Scientific studies have proven that Risperdal increases levels of prolactin, a hormone that stimulates breast development. As a result, young boys who have been exposed to prolactin may develop male breasts with pain or nipple discharge. A study in the 2006 issue of the Journal of Clinical Psychopharmacology states that when Risperdal is administered in usual doses, it can “strongly increase prolactin levels, with clinical consequences such as gynecomastia.” Although the potential for gynecomastia from taking Risperdal is now well understood, the long-term effects of Risperdal are not well known. Risperdal could potentially impact boys’ development and puberty.
Johnson & Johnson Failed to Warn of Risperdal Risks
Current Risperdal labeling warns that unusual breast growth could be a side effect of taking the drug. However, when the FDA first approved Risperdal, Johnson & Johnson provided insufficient warnings that their product could cause gynecomastia in a large percentage of people who use it. As a result, many boys have experienced harmful physical and psychological side-effects. Hundreds of people across the country have already filed lawsuits against Johnson & Johnson for their failure to warn consumers and healthcare providers of the potential for Risperdal to cause gynecomastia and other side effects.
In September 2012, Johnson & Johnson reached an agreement to settle one such case on the first day of trial in Philadelphia state court, but the amount of the settlement remains confidential. Those who have filed Risperdal lawsuits are requesting monetary damages for hospital expenses, surgical costs, mental anguish, and other damages. If you feel that you, or someone you know, should be compensated for side effects caused by Risperdal, please contact us to speak with a Risperdal attorney today. All consultations are free and completely confidential.
Pharmaceutical Negligence $46 Million
Brain Injury Due to Defective Medical Device $16 Million
Injuries Caused by Mining Disaster $11 Million
Injuries to Foster Child From Abuse - Gov’t Agency $10 Million
Injuries Due to Negligent Operation of Train $6.1 Million
Child Injured at Birth - Umbilical Cord Compression $5.4 Million
Injured by Defective Helmet & Negligent Track Employees $3.5 Million
Child Injured at Birth – Deprived of Oxygen $2.9 Million
Injured Forklift Operator $2.5 Million
Burns from Flammable Bathrobe $2 Million
Our legal team understands what you are going through and is committed to defending your rights against powerful businesses and insurance carriers.
Committed to the Community
Our advocacy extends beyond the courtroom through our extensive involvement in the community and support for positive change within our industry.
Fearless Advocacy When You Need It
Our experienced legal team is not afraid to go to trial in order to maximize the recovery that our clients desperately need and rightfully deserve.
Respected within the Legal Field
Our esteemed attorneys are highly regarded within the legal community and even command respect from adjustors and defense counsel.
At the Forefront of Major Litigation
Our legal team has spearheaded litigation on behalf of injured clients in many high-profile cases, including major disasters, explosions and sexual abuse cases.
A Long Legacy of Successful Results
Since its founding in 1953, Ashcraft & Gerel has obtained more than a billion dollars in successful verdicts and settlements for injured clients.